FDA Warns Sun Over Oxycodone Quality Control Issues
The U.S. Food and Drug Administration has faulted a unit of Sun Pharma Global Inc. for lapses in quality control the regulator blames for "imploding" bottles of gemfibrozil, "sweating" nimodipine capsules...To view the full article, register now.
Already a subscriber? Click here to view full article